RegMedNet

Researchers UCLA have developed a novel platform that mimics the natural environment needed to enhance T cell-based therapies in the lab. Read on to see how Enbo Zhu, Lili Yang, Jiaji Yu, Yu Huang and team developed this platform that could enhance the protocols in CAR-T development and manufacturing >>> https://lnkd.in/eNUy2xEF

A novel CAR-T cell therapy targeting CD7 has proven effective in treating relapsed or refractory T-cell acute lymphoblastic leukemia. Read about it here >>> https://hubs.ly/Q02SYsV20

This week, three strategic partnerships have been established among six biotechnology companies, each addressing key challenges in cell and gene therapy innovation. Learn more about the impact of these collaborations in our weekly industry news round-up >>> https://hubs.ly/Q02SXlHz0

Are your raw materials hindering your cell quality and potency? Early-stage process screening could be the answer! Take a look at this Tech digest, sponsored by Sartorius, to discover more on screening for cell-based therapy manufacturing >>> https://hubs.ly/Q02LHQJn0

Come visit us at the ESGCT Congress in Rome! We’ll be at booth A14 with our spinning wheel and lots of giveaways, including copies of The Glossary for Advanced Therapies!

[WEBINAR] Regulatory considerations when choosing stem cell media! Oren Ben-Yosef, Product Manager for Stem Cells, Advanced Therapies at Sartorius, presents this webinar providing a guide through the essential criteria for choosing the correct stem cell media and supplier. Register now >>> https://hubs.ly/Q02M_s1f0

Decoding raw material quality and regulatory standards in cell and gene therapy! Understand the relationship between raw material selection and CGT manufacturing success in this webinar. Register now >>> https://hubs.ly/Q02QMhcK0 Sartorius

This week's newsletter includes: 🗞️ An upcoming webinar that will explore the common misconceptions and key considerations for selecting critical raw materials used in cell and gene therapies 🗞️ The discovery of a new progenitor cell type highlights potential for regenerative wound healing 🗞️ The top 3 grants in regenerative medicine: September 2024

Have you caught up on the latest news in cell and gene therapy? Get caught up now >>> https://hubs.ly/Q02S2fKC0 The news highlights include: 👉 A research collaboration between Prime Medicine, Inc. and Bristol Myers Squibb to develop and commercialize ex vivo T-cell therapies 👉 Positive Phase I data for BlueRock Therapeutics' investigational Parkinson’s disease cell therapy 👉 CARVYKTI demonstrates significant survival benefits in patients with multiple myeloma

From early breakthroughs in gene editing technologies to the design of cell-based therapies for cancer and genetic disorders, explore pivotal developments in the field of cell and gene therapies in our 10th birthday eBook >>> https://hubs.ly/Q02R_ykZ0